🇺🇸 FDA
Patent

US 7915267

Heterocyclic amide compound and use thereof

granted A61PA61P1/00A61P1/02

Quick answer

US patent 7915267 (Heterocyclic amide compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/16, A61P11/06